Related references
Note: Only part of the references are listed.Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich's Ataxia
Daniel Velasco-Sanchez et al.
CEREBELLUM (2011)
Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
Jodie L. Babitt et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Iron Regulatory Proteins: From Molecular Mechanisms to Drug Development
Stefania Recalcati et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia
Barbra J. Sasu et al.
BLOOD (2010)
Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation
Or Kakhlon et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?
Iain C. Macdougall
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Anemia of Chronic Disease (Anemia of Inflammation)
Neeraj Agarwal et al.
ACTA HAEMATOLOGICA (2009)
Specific iron chelators determine the route of ferritin degradation
Ivana De Domenico et al.
BLOOD (2009)
Absence of functional Hfe protects mice from invasive Salmonella enterica Serovar Typhimurium infection via induction of lipocalin-2
Manfred Nairz et al.
BLOOD (2009)
Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications
Igor Theurl et al.
BLOOD (2009)
New Pharmacological Concepts for the Treatment of Iron Overload Disorders
Sabine M. Mair et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Iron Metabolism, Iron Deficiency, Thrombocytosis, and the Cardiorenal Anemia Syndrome
Anatole Besarab et al.
ONCOLOGIST (2009)
Recycling Iron in Normal and Pathological States
Carole Beaumont et al.
SEMINARS IN HEMATOLOGY (2009)
Iron-Refractory Iron Deficiency Anemia
Karin E. Finberg
SEMINARS IN HEMATOLOGY (2009)
Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation
Or Kakhlon et al.
BLOOD (2008)
Iron depletion limits intracellular bacterial growth in macrophages
Prasad N. Paradkar et al.
BLOOD (2008)
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Paul B. Yui et al.
NATURE CHEMICAL BIOLOGY (2008)
Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism
G. Lescoat et al.
CELL PROLIFERATION (2007)
The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium
Manfred Nairz et al.
CELLULAR MICROBIOLOGY (2007)
Selective iron chelation in Friedreich ataxia:: biologic and clinical implications
Nathalie Boddaert et al.
BLOOD (2007)
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
Jodie L. Babitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease
Hiroshi Kawabata et al.
HAEMATOLOGICA (2007)
Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences
Hava Glickstein et al.
BLOOD (2006)
The evolution of iron chelators for the treatment of iron overload disease and cancer
DS Kalinowski et al.
PHARMACOLOGICAL REVIEWS (2005)
Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells
H Glickstein et al.
BLOOD (2005)
Medical progress: Anemia of chronic disease
G Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
E Nemeth et al.
SCIENCE (2004)
Iron and microbial infection
ME Schaible et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Cytokine-mediated regulation of iron transport in human monocytic cells
S Ludwiczek et al.
BLOOD (2003)
Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation
FM Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy
W Breuer et al.
BLOOD (2001)
Share Paper
